What is AVAVA Medical?
AVAVA Medical is at the forefront of dermatological innovation, leveraging proprietary 3D technology and advanced Skin AI visualization to offer personalized and effective treatments for all skin tones. Their smart energy platform delivers precise, predictable, and safe procedures with reduced pain and downtime, setting a new standard in aesthetic medicine. The company's technology transcends existing solutions by offering a highly tailored approach, ensuring consistent outcomes across a diverse patient base.
How much funding has AVAVA Medical raised?
AVAVA Medical has raised a total of $54.6M across 3 funding rounds:
Other Financing Round
$10M
Series C
$25M
Private Equity
$19.6M
Other Financing Round (2024): $10M with participation from Catalio Capital Management
Series C (2024): $25M led by Jeisys Medical
Private Equity (2026): $19.6M, investors not publicly disclosed
Key Investors in AVAVA Medical
Catalio Capital Management
Catalio Capital Management is a New York-based investment firm specializing in innovative healthcare investing across private, public, and credit markets, focusing on breakthrough biomedical technology companies.
Jeisys Medical
Jeisys Medical is a leading K-beauty medical technology company specializing in advanced RF treatment systems, particularly their flagship product DENSITY, aiming to redefine aesthetic device expectations.
What's next for AVAVA Medical?
With this major enterprise-level funding, AVAVA Medical is poised to accelerate its research and development, expand its market reach, and further enhance its groundbreaking technology. The strategic investment signals strong confidence from backers in the company's vision and its potential to disrupt the medical aesthetics industry. Future initiatives will likely focus on scaling production, broadening clinical applications, and solidifying strategic partnerships to drive widespread adoption of their advanced skin treatment solutions.
See full AVAVA Medical company page
